Federation des caisses Desjardins du Quebec’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2 | Sell |
1
-2
| -67% | -$4 | ﹤0.01% | 2718 |
|
|
2025
Q1 | $6 | Sell |
3
-4
| -57% | -$8 | ﹤0.01% | 2644 |
|
|
2024
Q4 | $42 | Hold |
7
| – | – | ﹤0.01% | 2521 |
|
|
2024
Q3 | $69 | Hold |
7
| – | – | ﹤0.01% | 2504 |
|
|
2024
Q2 | $145 | Hold |
7
| – | – | ﹤0.01% | 2323 |
|
|
2024
Q1 | $319 | Hold |
7
| – | – | ﹤0.01% | 2272 |
|
|
2023
Q4 | $333 | Hold |
7
| – | – | ﹤0.01% | 2229 |
|
|
2023
Q3 | $286 | Hold |
7
| – | – | ﹤0.01% | 2253 |
|
|
2023
Q2 | $753 | Hold |
7
| – | – | ﹤0.01% | 2161 |
|
|
2023
Q1 | $2.11K | Hold |
7
| – | – | ﹤0.01% | 2074 |
|
|
2022
Q4 | $2.43K | Hold |
7
| – | – | ﹤0.01% | 2176 |
|
|
2022
Q3 | $1.34K | Hold |
7
| – | – | ﹤0.01% | 2313 |
|
|
2022
Q2 | $1.49K | Hold |
7
| – | – | ﹤0.01% | 2349 |
|
|
2022
Q1 | $2.36K | Hold |
7
| – | – | ﹤0.01% | 2333 |
|
|
2021
Q4 | $2.3K | Hold |
7
| – | – | ﹤0.01% | 2340 |
|
|
2021
Q3 | $3.43K | Buy |
7
+4
| +133% | +$1.96K | ﹤0.01% | 2339 |
|
|
2021
Q2 | $1.16K | Buy |
+3
| New | +$1.16K | ﹤0.01% | 2429 |
|